摘要:
本发明涉及化合物的公式(I)## STR1 ##其中A为苯,萘,5,6,7,8-四氢萘,喹啉,异喹啉,吲哚或7-氮杂吲哚; R.sub.1为--H,--CN,--SO.sub.3R.sub.4--,--SO.sub.2NHR.sub.5,## STR2 ## --COOR.sub.6,--CONHCH.sub.2(CHOH).sub.n CH.sub.2OH,## STR3 ## --NR.sub.7R.sub.8,--N(CH.sub.2CH.sub.2OH).sub.2,--NHCH.sub.2(CHOH).sub.n CH.sub.2OH,--NHCONH.sub.2,--NH--C(NH.sub.2).dbd.NH,--NHCO(CHOH).sub.n CH.sub.2OH,## STR4 ## --NHSO.sub.2R.sub.9,--OR.sub.10,--OCH.sub.2(CHOH).sub.n CH.sub.2OH,--OOC(CHOH).sub.n CH.sub.2OH,--OPO(OH).sub.2,--CH.sub.2NH.sub.2,--C(NH.sub.2).dbd.NH,--CH.sub.2NHC(NH.sub.2).dbd.NH,## STR5 ## --CH.sub.2OH,--CH.sub.2OOC(CHOH).sub.n CH.sub.2OH,--CH.sub.2OPO(OH).sub.2或--PO(OH).sub.2; R.sub.2为C.sub.1-C.sub.6烷基,卤素或羟基; R.sub.3为--H或C.sub.1-C.sub.6烷基; R.sub.4为--H,C.sub.1-C.sub.6烷基或--CH.sub.2(CHOH).sub.n CH.sub.2OH; R.sub.5为--H,C.sub.1-C.sub.6烷基,--CH.sub.2(CHOH).sub.n CH.sub.2OH或--(CH.sub.2).sub.m NMe.sub.2; R.sub.6为--H,C.sub.1-C.sub.6烷基或--CH.sub.2(CHOH).sub.n CH.sub.2OH; R.sub.7和R.sub.8中的每一个独立地为--H或C.sub.1-C.sub.6烷基; R.sub.9为甲基或甲苯基; R.sub.10为--H,C.sub.1-C.sub.6烷基或C.sub.2-C.sub.6烷酰基; Z为> CH.sub.2,> O,> NH或> NCH.sub.2CH.sub.2OH; n为零或1; m为2或3; p为1,2或3; q为零,1或2;以及其药学上可接受的盐,用作酪氨酸激酶抑制剂。